Pediatric Clinical Trials

Acute Lymphoblastic Leukemia (Pediatric)

Acute Myelogenous Leukemia (Pediatric)

Anemia (Pediatric)

Brain Tumors (Pediatric)

Chronic Myelogenous Leukemia (Pediatric)

General Malignancies (Pediatric)

Germ Cell Tumors (Pediatric)

Immune Thrombocytopenia Purpura (Pediatric)

Lymphoma (Pediatric)

Medulloblastoma (Pediatric)

Neuroblastoma (Pediatric)

Osteosarcoma (Pediatric)

Sickle Cell Anemia (Pediatric)
Disease Type
Disease Type
Status
Trial Status
Filter by disease/Status
A Phase 3 Study for Newly Diagnosed Rhadomyosarcoma
ARST2032: A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Status: Open
Trial Type: Rhabdomyosarcoma
Contact: Jennifer Welch, MD
jwelch@lifespan.org
A Randomized Phase 3 Trial for High Risk Rhabdomyosarcoma
ARST2031: A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
Status: Open
Trial Type: Rhabdomyosarcoma
Contact: Jennifer Welch, MD
jwelch@lifespan.org
PHO-TEaM – (BCC16)
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
Status: Open
Trial Type: Brain Tumors (Pediatric)
Contact: Jennifer Welch, MD
jwelch@lifespan.org

©2023 Brown Cancer Clinical Trials